通过利用语音基础模型检测早期帕金森病
IEEE journal of biomedical and health informatics
|March 7, 2025
概括
像wav2vec2.0,Whisper和SeamlessM4T这样的语音基础模型显示出早期帕金森病 (PD) 检测的前景. 微调这些模型实现了91.35%的AUC,与临床数据相关.
科学领域:
- 神经学 神经学
- 语音科学 语言科学
- 人工智能的人工智能
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,具有早期言语和声音变化.
- 语音基础模型为语音处理和特征提取提供了高级功能.
研究的目的:
- 通过使用语音录音来评估wav2vec2.0,Whisper和SeamlessM4T在早期发现帕金森病的疗效.
- 为了比较直接特征提取与PD分类的模型微调方法.
主要方法:
- 使用了三个最先进的语音基础模型:wav2vec2.0,Whisper和SeamlessM4T.
- 实验了PD分类的直接特征提取和微调策略.
- 根据临床和神经成像数据验证模型性能,包括DaTSCAN分数.
主要成果:
- 与直接特征提取相比,微调基础模型产生了更高的性能.
- 在ICEBERG数据集上实现了91.35%的曲线下面区域 (AUC) 的最新状态.
- 模型预测与临床评估和DaTSCAN分数有显著的相关性.
结论:
- 语音基础模型是早期检测帕金森病的可行工具.
- 微调这些模型提供了一种强大而准确的方法来通过语音分析来诊断PD.
- 使用人工智能的语音分析有可能用于非侵入性早期PD查.
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment
178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
Parkinson's Disease: Overview
415
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
415


